---
title: "AVS completes US$36 million Series B financing ahead of IVL US commercial launch"
date: "2025-01-29T08:14:46.000Z"
publishedDate: "29 janvier 2025"
summary: "Amplitude Vascular Systems (AVS) recently announced that it has completed a Series B round of financing of US$36 million. The funding will support the US peripheral commercial launch as well as US coronary and carotid investigational device exemption (IDE) trials for the company’s Pulse intravascular lithotripsy (PIVL) device."
importance: ""
sourceUrl: "https://cardiovascularnews.com/avs-completes-us36-million-series-b-financing-ahead-of-ivl-us-commercial-launch/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-01-29-avs-completes-usdollar36-million-series-b-financing-ahead-of-ivl-us-commercial-launch"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/01/AVS_Full-System-W-Screen-1-JPEG-HI-RES.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/avs-completes-us36-million-series-b-financing-ahead-of-ivl-us-commercial-launch/"
---

![AVS completes US$36 million Series B financing ahead of IVL US commercial launch](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/01/AVS_Full-System-W-Screen-1-JPEG-HI-RES.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/avs-completes-us36-million-series-b-financing-ahead-of-ivl-us-commercial-launch/*

## L’essentiel

Amplitude Vascular Systems (AVS) recently announced that it has completed a Series B round of financing of US$36 million. The funding will support the US peripheral commercial launch as well as US coronary and carotid investigational device exemption (IDE) trials for the company’s Pulse intravascular lithotripsy (PIVL) device.

## Lien source

https://cardiovascularnews.com/avs-completes-us36-million-series-b-financing-ahead-of-ivl-us-commercial-launch/
